Blog

Amol Akhade: Data to look forward at AACR2025

Amol Akhade/hiranandanihospital.org

Apr 25, 2025, 11:15

Amol Akhade: Data to look forward at AACR2025

Amol Akhade, Senior consultant medical oncologist and hemato-oncologist at Suyog Cancer Clinics and Reliance Hospitals, shared a post on LinkedIn:

“At AACR25, dive into essential sessions for the data-rich AACR Annual Meeting.

Check out what sessions to look out for –

Discover:

Perioperative immunotherapy in head and neck cancer at KEYNOTE-689.
Tumor-agnostic ctDNA-directed strategies.
Breakthrough data on WRN, KRAS G12D, and BRAF paradox.
Explore SENTI-202, SHR-A1811, and cutting-edge bi-specific ADCs.
Unveil digital twins, MSI-H, spatial omics, and more.”

Amol Akhade: Data to look forward at AACR2025

AACR Annual Meeting AACR2025 Amol Akhade BRAF cancer ctDNA fight against cancer Global fight against cancer Head and Neck Cancer immunotherapy Keynote-689 KRAS G12D OncoDaily Oncology Reliance Hospitals SENTI-202 SHR-A1811 Suyog Cancer Clinics WRN

FDA Priority Review Granted for TAR-200 After 82% Complete Response in BCG-Unresponsive Bladder Cancer

Paolo Tarantino: AACR Journals' Power Move for Reviewers

Best Immunotherapy Highlights from ESMO TAT ASIA 2025 You Shouldn't Miss

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership

Mohit Manrao: FDA Grants Priority Review for sBLA in Resectable Early-Stage Gastric and GEJ Cancers